APR 22, 2020 7:24 AM PDT

Only 3% of COVID-19 Antibody Tests Approved by FDA

WRITTEN BY: Annie Lennon

So far, only 3% of at least 90 COVID-19 antibody tests in the US have been approved by the Food and Drug Administration (FDA). This comes as relaxed rules by the agency have allowed untested and potentially unreliable tests for COVID-19 to enter the market, something that may slow down the country’s recovery from the virus. 

Although antibody tests are not the best indicator of whether someone has COVID-19, they may be able to tell if someone has had it already. Officials from the Association of Public Health Laboratories (APHL) have thus said that they are a crucial tool to inform the country’s response to the pandemic. However, in light of the at least 90 antibody tests that have flooded the market in recent weeks, doctors and health officials alike are apprehensive about their accuracy and reliability. 

“We now have at least 90 tests on the market, and we don’t know about the accuracy of the results,” says Kelly Wroblewski, APHL’s director of infectious disease programs. “Having many inaccurate tests is worse than having no tests at all.”

Currently, the FDA mandates that private companies may certify the accuracy and reliability of antibody tests themselves before bringing them to market, rather than let a third party conduct a test. In doing so however, they are not able to claim that their tests were authorized by the FDA and must include disclaimers about their accuracy. 

To achieve full FDA approval, the agency has left test developers the option of going through the agency’s emergency authorization process. Despite this however, only three companies have undergone and been approved by the process so far, meaning that the vast majority of antibody tests on the market have not been certified by the FDA to actually work. 

In being able to tell whether someone has already had the virus, reliable antibody tests are crucial to understand what percentage of the population has already developed an immune response to the disease, and thus who may be able to go back to work. 

False negatives may mean that people already potentially immune to the disease are needlessly prevented from going back to work. Meanwhile, false positives may mean that people who have not had the virus before go back to work, something that may cause a second wave of cases if not properly managed. 



Sources: USA Today, FDA, LabRoots

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
SEP 30, 2021
Cannabis Sciences
Concerning New Evidence Regarding Cannabis Use During Pregnancy
SEP 30, 2021
Concerning New Evidence Regarding Cannabis Use During Pregnancy
According to data from a National Vital Statistics Report published in March 2021, the percentage of infants born with a ...
OCT 07, 2021
Drug Discovery & Development
Extended approval for a drug to treat children living with HIV
OCT 07, 2021
Extended approval for a drug to treat children living with HIV
On Monday October 4th, ViiV Healthcare announced that it had submitted an application to the United States Food and Drug ...
OCT 14, 2021
Immunology
'Bio-Betters' Form the Next Wave of Cancer Therapies
OCT 14, 2021
'Bio-Betters' Form the Next Wave of Cancer Therapies
  Antibodies are blood proteins with highly specialized functions: to recognize and eliminate bacteria, viruses, an ...
OCT 28, 2021
Immunology
Unlocking a New Target to Treat Gut Inflammation
OCT 28, 2021
Unlocking a New Target to Treat Gut Inflammation
  Immunologists have uncovered a molecular switch in T cells that serves as a prime target for therapeuti ...
NOV 10, 2021
Drug Discovery & Development
Inflammation during pregnancy can affect normal brain development
NOV 10, 2021
Inflammation during pregnancy can affect normal brain development
During pregnancy the growing embryo and fetus undergo remarkable and quick developmental. Around 5 weeks after ...
NOV 20, 2021
Neuroscience
Fear balance - the brain and body communicate to maintain fear within an adaptive range
NOV 20, 2021
Fear balance - the brain and body communicate to maintain fear within an adaptive range
We have all experienced the emotion of fear. Although what one individual might fear (e.g. rollercoasters or snakes), mi ...
Loading Comments...